CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents High-Risk Coronary Atherosclerosis Is It the Plaque Burden, the Calcium, the Lipid, or Something Else? A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations Association Between Living in Food Deserts and Cardiovascular Risk 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed The Elusive Late Benefit of Biodegradable Polymer Drug-Eluting Stents The Year in Cardiovascular Medicine 2020: Coronary Intervention

Volume 75, Issue 16, April 2020

JOURNAL:JACC Article Link

2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization)

GJ Dehmer, V Badhwar, EA Bermude et al. Keywords: ACC/AHA Clinical Data Standards; ACS; CHD; PCI; CABG; coronary revascularization; clinical trials

Full Text PDF